Skip to main content

PRESS RELEASE

The Belgian health ecosystem shows a strong dedication to the European Event HealthTech Innovation Days on 13-14 October in Paris

 

• BioWin, Flanders.bio and Medvia, the three leading clusters of the Belgian healthtech ecosystem, are partners of the event, alongside 16 other European clusters.

• 20 Belgian healthtech and life science investment companies will attend HealthTech Innovation Days.

• 9 Belgian start-ups are competing in the first edition of the HealthTech For Care Innovation Award, a pitch contest, along with 25 innovative European health companies.

Paris, Brussels, October 6, 2022 HealthTech Innovation Days (HTID®), organised by the HealthTech For Care (HTFC) endowment fund, on October 13 and 14, 2022 in Paris, has been increasing the participation of European companies for four years now. To date, more than 150 companies are participating in HTID, including 20 Belgian companies.

This European event combines one-to-one meetings between innovative European health companies (Biotech, Medtech, Innovative Services & Digital Health), investors, industrial and pharmaceutical players, as well as conferences and round tables led by international opinion leaders.

“Belgium is world-renowned for its vaccine production, its number of clinical trials per capita and its ambition to foster a network of companies in order to create a dynamic European healthcare ecosystem with international reach. Belgium ranks third in Europe in its share of biopharmaceutical employment with 42,000 employees in the industry, including more than 6000 researchers (2021). We want to grow our business with the highly skilled workforce present in Europe; they are one of the key pillars of the success of the Belgian biopharmaceutical sector.” BioWin, flanders.bio and Medvia.

“We are delighted with the Belgian collaborations as well as with all the European clusters that contribute to making the HealthTech Innovation Days a leading event in Europe for health innovation players. We hope to facilitate and strengthen the partnerships between all the actors of the European ecosystem for patient care”. said Maryvonne Hiance, President of HealthTech For Care, organiser of the HTID®.

HealthTech For Care benefits from the support of its founder France Biotech and the network of French health clusters: Atlanpole biotherapies, BioValley France, EuroBioMed, LyonBioPole, Medicen and the NSL clubster. The endowment fund is also supported by many European players: Asebio, BioAlps, BIO Deutschland, BioWin, CEBR, Federchimica Assobiotec, flanders.bio, Medvia, HollandBIO, IREFI, Swiss Biotech and French: Business France.

The 4th edition of the HealthTech Innovation Days (HTID®) event is supported by sponsors: Agile Capital Markets, Amgen France, BNP Paribas , Bpifrance, Bristol Myers Squibb, Cenponts, Cepton Strategies/Vintura, Dechert, EIT Health, Euronext, Ferring, Jeito CapitalIcosa, Alpha Blue Ocean, Invest Securities, Ipsen, Leem (Les Entreprises du Médicament), Life Sciences Acceleration Alliance, McDermott Will & Emery, Organon, Rothschild&Co, Sanofi, Servier, Sofinnova Partners, Stifel.

About HealthTech For Care

The HealthTech For Care endowment fund is designed to support and promote access to healthcare for all, and more specifically to new medical technologies and medicines. The missions of the endowment fund are organised around three main areas: to support the development of the entire healthcare ecosystem, to accelerate the development of innovative therapies and medicines, and to promote better access for patients to the healthcare system in France and Europe. The governance of HealthTech For Care includes Maryvonne Hiance, Elsy Boglioli, David Caumartin, Pierre Courteille, Marc Dechamps, Eric Falcand, Frédéric Girard, Marc Julien, Anaïs Le Corvec, Cédric Moreau, Christian Pierret and Christian Policard.

https://www.linkedin.com/company/healthtech-for-care/

https://htfc-eu.com

About HealthTech Innovation Days

The HTID® event, initiated by France Biotech, provides a platform for promising European life sciences companies to accelerate their growth and bring innovation to patients. This European event gathers each year more than 800 participants including 300 global investors, 150 innovative European healthcare companies and about 15 pharmaceutical groups. The 4th edition will take place on October 13 and 14, 2022 under a hybrid format, combining in-person presentations, panels and one-on-one meetings in Paris with a virtual platform. It is organised by the HealthTech For Care endowment fund. The HealthTech Innovation Days are sponsored by international pharmaceutical companies, other health innovation companies, investors and many international opinion leaders.

https://htfc-eu.com/htid/

Press Relations

Margaux Puech

mpuech@ulysse-communication.com

+33(0)7 86 16 01 09

Press Relations

Pierre-Louis Germain

plgermain@ulysse-communication.com

+33(0)6 64 79 97 51

HTFC

Nathalie Donne

nathalie.donne@insead.eu

+33(0)6 67 67 44 97

HTFC

Solène Goupy

solene.goupy@htfc-eu.com

+33(0)6 38 03 80 19

Leave a Reply